Posted By
Tags
- 3
- A
- Administration
- Almost
- Approval
- Benefit
- Benefits
- Biologic
- Biopharmaceutical
- Cast
- Center for Biologics Evaluation and Research
- Data
- Deference
- Document
- Drug
- Duchenne
- Evaluation
- Evening
- Exclusive
- Expansion
- Fact
- Failure
- FDA
- Food
- Food and Drug Administration
- Gene therapy
- Last year
- Lieutenant
- Marks
- MUSCULAR
- Overrule
- Overruled
- Patient
- Peter Mark
- Peter Marks
- Pharmaceutical drug
- Phase
- Phase 3
- Phase 3 trial
- Prevailing
- Research
- Sarepta
- Sarepta Therapeutics
- Teams
- Therapy
- Third
- Three
- Top
- Trial
- Uncertainty
- Wheelchair
- Who